Cargando…

Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142891/
https://www.ncbi.nlm.nih.gov/pubmed/34041039
http://dx.doi.org/10.3389/fonc.2021.694036
_version_ 1783696642564685824
collection PubMed
description
format Online
Article
Text
id pubmed-8142891
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-81428912021-05-25 Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer Front Oncol Oncology Frontiers Media S.A. 2021-05-10 /pmc/articles/PMC8142891/ /pubmed/34041039 http://dx.doi.org/10.3389/fonc.2021.694036 Text en Copyright © 2021 Frontiers Editorial Office https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
title Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
title_full Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
title_fullStr Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
title_full_unstemmed Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
title_short Retraction: CRISPR/Cas9-Mediated OC-2 Editing Inhibits the Tumor Growth and Angiogenesis of Ovarian Cancer
title_sort retraction: crispr/cas9-mediated oc-2 editing inhibits the tumor growth and angiogenesis of ovarian cancer
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142891/
https://www.ncbi.nlm.nih.gov/pubmed/34041039
http://dx.doi.org/10.3389/fonc.2021.694036
work_keys_str_mv AT retractioncrisprcas9mediatedoc2editinginhibitsthetumorgrowthandangiogenesisofovariancancer